Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorder and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.
Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder.
Headquartered in the United States in Richmond, VA, Indivior employs more than 800 individuals globally and its portfolio of products is available in over 40 countries worldwide.
Our guiding principles foster a corporate culture of trust, innovation, and a pioneering spirit:
• Focus on patient needs to drive decisions
• Seek the wisdom of the team
• Believe that people’s actions are well intended
• Care enough to coach
• See it, own it, make it happen
• Demonstrate honesty and integrity at all times
opioid use disorder, alcohol use disorder, rescue medications, schizophrenia